Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute, Naples
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
University of Wisconsin, Madison
National Cancer Institute (NCI)
ALX Oncology Inc.
University of Pittsburgh
University of California, San Diego
The Methodist Hospital Research Institute
Buzzard Pharmaceuticals
UMC Utrecht
Gustave Roussy, Cancer Campus, Grand Paris
National Institutes of Health Clinical Center (CC)
University of Washington
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
QBiotics Group Limited
Memorial Sloan Kettering Cancer Center
Grupo Español Multidisciplinar de Melanoma
BicycleTx Limited
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
I-Mab Biopharma US Limited
Northwestern University
Memorial Sloan Kettering Cancer Center
Institut Curie
Gruppo Oncologico del Nord-Ovest
University of Utah
Hackensack Meridian Health
University of Vermont Medical Center
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
University of Oklahoma
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
AstraZeneca
Dartmouth-Hitchcock Medical Center
Fudan University
Riboscience, LLC.